Frequency Therapeutics Inc is a biotechnology business based in the US. Frequency Therapeutics shares (FREQ) are listed on the NASDAQ and all prices are listed in US Dollars. Frequency Therapeutics employs 72 staff and has a market cap (total outstanding shares value) of 0.00.
Our top pick for
Beginners
Our top pick for
Free trades
Our top pick for
Active traders
| Latest market close | $1.90 |
|---|---|
| 52-week range | $1.00 - $7.88 |
| 50-day moving average | $2.07 |
| 200-day moving average | $2.66 |
| Wall St. target price | $8.00 |
| PE ratio | N/A |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $-2.54 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $1.9 from 2022-09-28
| 1 week (2022-09-22) | 5.56% |
|---|---|
| 1 month (2022-08-29) | -10.38% |
| 3 months (2022-06-29) | 24.18% |
| 6 months (2022-03-25) | N/A |
| 1 year (2021-09-29) | -72.90% |
|---|---|
| 2 years (2020-09-29) | -90.38% |
| 3 years (2019-09-25) | N/A |
| 5 years (2017-09-25) | N/A |
| Gross profit TTM | $14.1 million |
|---|---|
| Return on assets TTM | -30.71% |
| Return on equity TTM | -69.74% |
| Profit margin | 0% |
| Book value | $2.74 |
| Market capitalisation | $66.6 million |
TTM: trailing 12 months
We're not expecting Frequency Therapeutics to pay a dividend over the next 12 months.
Over the last 12 months, Frequency Therapeutics's shares have ranged in value from as little as $1 up to $7.88. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Frequency Therapeutics's is 0.7351. This would suggest that Frequency Therapeutics's shares are less volatile than average (for this exchange).
Frequency Therapeutics, Inc. , a clinical-stage biotechnology company, focuses on developing therapeutics to activate a person's innate regenerative potential to restore function. Its Progenitor Cell Activation approach uses small molecules and activate progenitor cells within the body to create functional tissue. The company's lead product candidate is FX-322, which is in Phase IIa clinical trial to treat the underlying cause of sensorineural hearing loss. It is also developing medicines for patients across a range of degenerative conditions, including multiple sclerosis, and diseases of the muscle, gastrointestinal tract, skin, and bone. The company has a license and collaboration agreement with Astellas Pharma Inc. for the development and commercialization of FX-322, as well as collaboration and licensing agreements with Massachusetts Eye and Ear, the Massachusetts Institute of Technology, The Scripps Research Institute, and Cambridge Enterprises Limited.
Looking to invest in tech? Here’s how to buy shares in the major tech companies, known as FAANG stocks.
A simple guide to buying stocks in your favorite European soccer team.
Steps to owning and managing JUVE, with 24-hour and historical pricing before you buy.
Steps to owning and managing ASR, with 24-hour and historical pricing before you buy.
Steps to owning and managing BVB, with 24-hour and historical pricing before you buy.
Everything we know about the Lead Real Estate Co. IPO, plus information on how to buy in.
Everything we know about the Third Harmonic Bio IPO, plus information on how to buy in.
Everything we know about the LINKBANCORP IPO, plus information on how to buy in.
Here are the stocks that benefit from inflation, as well as industries to keep an eye on to reduce the impacts of inflation on your portfolio.
We’ve rounded up stats on some of the most popular wheat stocks, along with information on how these stocks compare and how to invest.